We have previously identified, based on the expression of the CD45RA and CD71 antigens, three major subpopulations of CD34+ cells derived from human umbilical cord blood: CD34+CD45RA1"CD71 lo cells (up to 42% multipotent progenitors), CD34+CD45RA+ CD71 lo cells (90% myeloid progenitors), and CD34+CD45RA1"CD71 + cells (70% erythroid progenitors). In the present study, we have investigated the long-term proliferation and differentiation of these subpopulations in response to hematopoietic cytokines. Cells from each subpopulation were cultured for 38 days in serum-and stroma-free liquid cultures supplemented with cytokine combinations that favor either erythropoiesis or myelopoiesis. In keeping with their high content of primitive progenitors, CD34+CD45RAbCD71 Io cells showed the highest CD34+ cell expansion (up to 532-fold) throughout the culture period, followed by CD34+CD45RA+CD7I1" (1 30-fold) and CD34+CD45RA-'"CD71 + (28-fold) cells. Interestingly, the cytokine combination favoring myelopoiesis was always more efficient in HE CELLS expressing the CD34 surface antigen con-T stitute a heterogeneous population of hematopoietic cells that includes primitive, uncommitted stem/progenitor cells capable of initiating long-term hematopoiesis in vitro,'-as well as more mature progenitors committed to different lineages of differentiation, eg, erythroid or CD34+ cells are present in different organs throughout development, ie, fetal liver, umbilical cord blood, adult peripheral blood, and adult bone marrow.''-'3 Interestingly, recent reports have presented evidence indicating that the CD34+ cells derived from such organs constitute functionally distinct cell populations, differing in their proliferative potential as well as in their responsiveness to hematopoietic cytokines.I6l6
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During the last few years, several groups of investigators have demonstrated that CD34' cells derived from different hematopoietic organs can be expanded in vitro in cultures supplemented with different cytokines; a procedure with potential applications in autologous transplantati~n.'~,'~~'~ Studies on the effects of defined culture conditions on dif-0 1993 by The American Society of Hematology.
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inducing CD34' cell expansion than the one favoring erythropoiesis. In all but one of the cultures, a predominance of myelopoiesis was observed after 2 weeks, even in those supplemented with the cytokine mixture that favors erythropoiesis. Only when CD34+CD45RA1"CD71 + cells were cultured in the presence of erythroid cytokine mixture, erythropoiesis was evident at all time points. However, such cultures could be sustained for only 29 days. The results of this study demonstrate that the cord blood-derived CD34' cell compartment consists of functionally distinct cell subpopulations that possess different proliferative capacities in vitro. Our results also show that the cytokine combinations used here were able to modulate proliferation and, to a much lesser extent, differentiation of such subpopulations, probably by favoring the expansion of committed progenitors rather than by acting on uncommitted cells. 0 1993 by The American Society of Hematology.
ferent CD34+ cell subpopulations are necessary to understand more clearly the effect of cytokines on functionally distinct hematopoietic cell types, and for the selection of conditions that favor either maintenance or expansion of desirable physiologic properties.
We have recently shown that CD34' cells derived from adult bone marrow or umbilical cord blood can be separated into different subpopulations based on their expression ofthe CD45RA (a leukocyte common antigen isoform) and CD7 1 (the transfemn receptor) antigens."." The vast majority of CD34' cells expressing high levels of CD45RA and low levels of CD7 1 (CD34+CD45RA+CD7 1'O cells) consisted of progenitors commited to the myeloid lineage of differentiation, whereas CD34+ cells expressing low levels of CD45RA and high levels of CD71 (CD34+CD45RA-'OCD71+ cells) are enriched for erythroid progenitors. In contrast, CD34+ cells expressing low levels of both CD45RA and CD7 1 (CD34+CD45RA"'CD7 1" cells) are particularly enriched for multipotent progenitor^.".'^ To characterize in more detail the functional properties of these cell subpopulations, especially in terms of their responsiveness to different hematopoietic cytokines, we have examined their proliferation and differentiation in a serum-free liquid culture system devoid of stromal cells and supplemented with cytokine combinations that favor either erythropoiesis or myelopoiesis. The cultures were sustained for up to 38 days, throughout which the numbers, phenotype, and in the case of progenitors, colony-forming capacity of the progenitor and mature cells produced were determined.
MATERIALS AND METHODS
Cell separation. Cord blood cells, collected according to institutional guidelines, were obtained during normal full-term deliveries. Low-density cells ( < I .077 g/mL) were isolated using Ficoll-Paque (Pharmacia LKB, Uppsala, Sweden), washed twice in phosphatebuffered saline (PBS), resuspended in Hanks' HEPES-buffered salt Cell culture. Purified CD34+CD45RAl°CD7 I", CD34'-CD45RA+CD7 1'O. and CD34+CD45RA1"CD7 1' cells were cultured in serum-free medium consisting of Iscove's modified Dulbecco's medium supplemented with bovine serum albumin (2%), insulin ( 10 pg/mL), transferrin (200 pg/mL), 2-mercaptoethanol ( mol/L), low-density lipoprotein (40 pg/mL), and pen-strep (lo2 U and 50 pg/mL, respectively)." The medium was supplemented with combinations of the following recombinant hematopoietic cytokines: mast cell growth factor or stem cell factor (MGF; 50 ng/mL), interleukin-6 (IL-6; 10 ng/mL), IL-3 (20 ng/mL), erythropoietin (Epo; 3 U/mL), granulocyte-macrophage colony-stimulating factor/IL-3 fusion protein (FP; 20 ng/mL), macrophage CSF (M-CSF 10 ng/mL), and granulocyte CSF (G-CSF 21 ng/mL). MGF, IL-3, IL-6, and FP were provided by Dr D. E. Williams (Immunex, Seattle, WA). Epo and G-CSF were provided by colleagues in our laboratory. M-CSF was a gift from Genetics Institute (Cambridge, MA). Control cultures contained no recombinant cytokines. Cells were cultured in 24-well tissue culture plates (Nunc, Kamstrup, Denmark) at 37"C, 5% COz, at a concentration of 1,000 cells/well. In some experiments, cells were cultured in 96-well tissue culture plates (Nunc) at 37"C, 5% CO,, at a concentration of 1 cell/well. Individual cells were plated by using an automated cell deposition unit (Becton Dickinson). At weekly intervals, cells were harvested from the wells, washed, counted in a hemocytometer using trypan blue, stained with MoAbs (as described above), and analyzed and re-sorted (CD34' cells) on a FACStar Plus.
Clonogenic assays. To determine their content of myeloid (CFU-C), erythroid (burst-forming unit-erythroid [BFU-E] and col- ony-forming unit-erythroid [CFU-E]), and multipotent (CFU-MIX) progenitors, cells harvested from the liquid cultures were plated in semisolid cultures, as described previo~sly,'~ at a concentration of 5,000 cells/mL. The cultures were supplemented with agar-leucocyte-conditioned medium ( 10% vol/vol; Media Preparation Service, Terry Fox Laboratory, Vancouver, Canada), Epo (3 U/mL), MGF (50 ng/mL), and FP (20 ng/mL).
RESULTS
Composition of CD34+ subpopulations. CD34+ cell subpopulations were separated according to their expression of the CD45RA and CD71 antigens (Fig 1) . As shown in Table 1 , and confirming our previous st~dies,",'~ CD34+CD45RAL0CD7 1'' cells were particularly enriched for multipotent progenitors (up to 42% of the total progenitor cell number), whereas CD34+CD45RA+CD7 1' ' and CD34+CD45RAl°CD7 1' cells were highly enriched for myeloid and erythroid progenitors, respectively. CD34+ cells expressing both CD45RA and CD7 1 were the least abundant ( Fig I ) and, in fact, in one experiment they were not clearly detected. Thus, they were not included in the present study. However, from our previous studies, it is known that such cells consist primarily of committed myeloid (60%) and erythroid (30%) progenitors. Fig 2) . This correlated with their low cloning efficiency observed in semisolid cultures (Table  I) . Among the proliferating cells of this subpopulation, the majority formed relatively small colonies of up to 5,000 cells in the presence of erythroid cytokine mixture, whereas almost 15% formed colonies of up to 50,000 cells when cultured in myeloid cytokine mixture. This is in keeping with the fact that the vast majority of these cells consisted of myeloid progenitors. No colonies of more than 50,000 cells were observed in either cytokine combination. Seventy eight percent of CD34+CD45RAt0CD7 I + cells proliferated in response to the cytokine combinations used (Fig 2) . This proportion of proliferating cells was similar to that observed in cultures of CD34+CD45RAIoCD7 1" cells, which correlated with the fact that both subpopulations had similar cloning efficiencies, higher than CD34+-CD45RA+CD7 1'' cells, in semisolid cultures ( Table 1) . In keeping with the fact that CD34+CD45RALoCD7 I + cells are enriched for erythroid progenitors, almost 40% of them responded to erythroid cytokine mixture by forming colonies of more than 50,000 cells.
Growth kinetics of CD34' cell subpopulations. To assess the long-term response of each of the CD34+ cell subpopulations to different cytokine combinations, cultures were initiated with 1,000 cells of the indicated phenotype in 1 mL of serum-free medium supplemented with either erythroid or myeloid cytokine mixture. Every 6 to 9 days the cells produced in culture were harvested, counted, stained with the antibodies indicated above, and analyzed by flow cytometry. Cells with a low side scatter and expressing the CD34 antigen were re-sorted and used to initiate subcultures at a concentration of 1,000 cells/culture. CD34' cell numbers were calculated from the percentage of cells with this phenotype times the total cell number at each time point. For days 1 6 to 38 the total number of CD34' cells was extrapolated from the number obtained at the previous harvest (eg, total CD34' cell number at day 1 6 equals total CD34+ cell number at day 8 times the number of CD34' cells in culture at day 1 6 divided by 1,000). Results shown correspond to a representative experiment (experiment 1 in Tables 2 and 3) . Two other experiments (experiments 2 and 3 in Tables 2   and 3) were performed in which the growth patterns observed were very similar to the one shown in this figure.
Progenitor cell expansion. Progenitor cell expansion was assessed by determining the number ofboth CD34+ and colony-forming cells (CFC) at different time points. As shown in Fig 3, a significant expansion of CD34' cells was observed in cultures initiated with CD34+CD45RAIoCD7 1'O cells. CD34+ cell expansion was also observed, although to lesser degrees, in cultures initiated with CD34'-CD45RAfCD7 1'' and CD34+CD45RAl°CD7 1' cells (Fig  3) . These results are in keeping with the fact that CD34+CD45RAIoCD7 1" cells are enriched for more primitive progenitors than the other two subpopulations (Table  1) . Interestingly, CD34+CD45RACCD7 1" cells showed a higher CD34+ cell expansion than CD34+CD45RA10CD7 1' cells, despite the fact that their cloning efficiency at day 0, both in semisolid and liquid cultures, was the lowest of all. This indicated that although CD34+CD45RA+CD7 1" cells contained lower numbers of CD34' progenitors at the beginning of the culture, they produced more CD34+ cells than the progenitors present in the CD34+CD45RA-'OCD7 1+ subpopulation. In fact, by day 29 the CD34' cell levels in this latter subpopulation were even lower than the input numbers at day 0.
At all time points, CD34' cell numbers were higher in cultures supplemented with myeloid cytokine mixture than in cultures containing erythroid cytokine mixture, which indicated that the cytokine environment had a direct effect in modulating the expansion of CD34' cells. Interestingly, from day 22 a continuous decrease in the CD34' cell numbers in all three subpopulations was observed. The rate of such a decrease was also dependent on the cytokine combination used, ie, it was more pronounced in cultures supplemented with erythroid cytokine mixture than in those supplemented with myeloid cytokine mixture (Fig 3) .
On days 8 and 29, the total CFC numbers were determined. As shown in Table 2 , a significant increase in clonogenic cell numbers was observed in cultures of CD34+CD45RAl0CD7 1" cells after 8 days of culture. The majority of such cells consisted of CFU-E and BFU-E when the cultures were supplemented with erythroid cytokine mixture, whereas most of the clonogenic cells were myeloid progenitors in cultures containing myeloid cytokine mixture. These results are in keeping with our previous report." By day 29 an even more dramatic increase in CFC levels was observed in cultures supplemented with both erythroid and myeloid cytokine mixtures (Table 2) . Interestingly, at this point only myeloid progenitors were detected in either cytokine combination.
When cultures were initiated with CD34TD45RA'CD-71" cells, the increase in CFC numbers on day 8, in the presence of either erythroid or myeloid cytokine mixture, was lower than the one observed with CD34'CD45RA-'OCD7 1' ' cells ( Results from three separate experiments, each one corresponding to a different cord blood. Fold-expansion numbers were calculated based on the progenitor cell numbers at day 8 and 29, and the input numbers at day 0. Numbers in parenthesis correspond to actual progenitor cell numbers. These numbers are given because no CFU-E were detected at day 0, thus it was not possible to calculate fold-expansion. erythroid cytokine mixture were committed to the erythroid lineage, only myeloid progenitors were observed in cultures containing myeloid cytokine mixture. By day 29 only a slight increase in CFC numbers was observed in cultures with erythroid cytokine mixture; in contrast, in cultures with myeloid cytokine mixture a further 20-to 70-fold increase in CFC numbers was observed. In both conditions, all the CFC observed at this point were myeloid progenitors ( Table 2) .
CFC numbers in day 8 cultures of CD34+CD45RA-' OCD7 1 + cells were significantly expanded, especially in the presence of erythroid cytokine mixture ( Table 2) . Ninety percent of such progenitors consisted of BFU-E and CFU-E in cultures with erythroid cytokine mixture, whereas 50% of the progenitors observed in cultures with myeloid cytokine mixture belonged to the myeloid lineage. After 29 days of culture, a dramatic decrease in CFC numbers was observed in the presence of erythroid cytokine mixture, all of them being CFU-E. This correlated with the decrease observed in CD34+ cell numbers in the same culture conditions (Fig 3) . In contrast, CFC numbers in cultures with myeloid cytokine mixture remained increased. However, at this point 100% of the progenitors belonged to the myeloid lineage ( Table 2 ). The discrepancy observed in this subpopulation between the poor expansion of CD34+ cells at day 8 and the significant expansion in CFC suggests that the vast majority of mature CFU-E and a proportion of BFU-E express low levels of CD34.
Total cell expansion.
To establish the degree oftotal cell expansion from CD34' cells from each subpopulation, we determined the average number of mature cells produced per CD34+ cell throughout the culture period. As shown in Table 3 , at day 8 of culture CD34+CD45RAl°CD7 1' cells cultured in erythroid cytokine mixture showed the highest proliferative response (875 to 1,933 cells produced per CD34' cell) among all three subpopulations. In contrast, CD34+CD45RAfCD7 1" cells cultured in either erythroid or myeloid cytokine mixture showed the lowest proliferative response. These results are in keeping with those observed in cultures of individual cells (Fig 2) . In cultures of CD34+CD45RAL0CD7 1" and CD34+CD45RA+CD7 1Io cells, the proliferative response of CD34' cells re-sorted on day 8 and used to initiate subcultures was significantly increased, whereas a significant reduction was observed in CD34+ cells from the CD34+CD45RAIoCD7 1+ subpopulation (Table 3) . After day 16, a continuous decrease was observed in the proliferation of CD34+ cells re-sorted at each time point. However, these observations need to be interpreted with caution, because we have shown that not all CD34+ cells from the same subpopulation have similar proliferative potentials (Fig 2) . The results presented in this section and in Table 3 correspond to average numbers, thus giving an estimation of the proliferative potential of each subpopulation as a whole; they are not indicative of individual cells.
To determine the type of mature cells being developed, CD34' CD45RA'" CD7 1 '"  ECM  1  180  765  118  61  36  2  202  846  140  53  40  3  79  131  32  11  6  MCM  1  105  270  70  66  45  2  161  40 1  107  51  42  3  34  66  41 Results correspond to three separate experiments, each consisting of a different cord blood. Numbers were calculated based on the total cell number at each time point and the input number of re-sorted CD34+ cells used to initiate each subculture. For example, ratios at day 16 were calculated based on the total cell number in culture at day 16 and the input number of CD34+ cells (1,000 CD34+ cells) used to initiate the subcultures on day 8.
phenotypic analysis of the total cells produced in cultures from each subpopulation was performed. As shown in Figs 4, 5, and 6, in the presence of myeloid cytokine mixture all three subpopulations showed a constant myeloid phenotype (low-high levels of CD45RA and intermediate levels of CD7 1). It is noteworthy that despite the low proportion of myeloid progenitors in the CD34+CD45I2ALoCD7 I + cell subpopulation at day 0 (12%), myelopoiesis predominated throughout the entire culture period in the presence of such a cytokine combination. This indicated that these cytokines For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From CYTOKINE EFFECT ON CD34' SUBPOPULATIONS 267 1 the production of myeloid cells was observed from day 22 (Figs 4 and 5) . It is noteworthy that the peak in the ratios shown in Table 3 for these two subpopulations in the presence of erythroid cytokine mixture, correlated with the erythroid phenotype observed at day 16. Only CD34+CD45RALoCD7 1' cells cultured in erythroid cytokine mixture showed an erythroid phenotype throughout the entire culture period (Fig 6) . However, these cultures could be sustained for only 4 weeks. The phenotypic profiles observed in culture correlated with the morphologic analysis (cytospin preparations stained with Wright-Giemsa) of the same cells, ie, cells with an erythroid phenotype (flow cytometric analysis) consisted of erythroblasts at different stages of maturation (morphologic analysis), and cells with a myeloid phenotype consisted of macrophages as well as immature and mature granulocytic cells.
DISCUSSION
The functional characterization of CD34+ cells has become of particular importance during the last few years, not only to understand the basic biology of hematopoiesis but also in terms of clinical applications. Indeed, it has recently been shown that enriched populations of CD34+ cells can be used for hematopoietic transplantation." In the present study we have separated cord blood-derived CD34+ cells on the basis of their expression of CD45RA and CD7 1. Confirming our previous ~tudies,'~.'~ we observed that CD34+CD45RAL0CD7 1I0 cells were enriched for multipotent progenitors, whereas CD34+CD45RA+CD7 1" and CD34+CD45RAIoCD7 1' cells were enriched for myeloid and erythroid progenitors, respectively.
By culturing these cells in serum-free liquid cultures, at a concentration of 1 or 1,000 cells/culture, we were able to demonstrate a marked heterogeneity in the proliferative potential between the different cell subpopulations and among the cells within each subpopulation. Furthermore, we showed that in all the cases, cell proliferation was directly modulated by hematopoietic cytokines. In terms of CD34+ cell numbers, CD34+CD45RA10CD7 1" cells showed the highest expansion throughout the entire culture period (38 days), followed by CD34+CD45RA+CD7 1'' and CD34+-CD45RAIOCD7 I+ cells, respectively. This observation is in keeping with the fact that the former subpopulation contained more immature progenitors than the other two subpopulations. Regardless of the cell subpopulation analyzed, expansion of CD34' cells was always better supported by myeloid (MGF + IL-6 + FP + M-CSF + G-CSF) than by erythroid (MGF + IL-6 + IL-3 + Epo) cytokine mixture.
Although the reason for this remains to be elucidated, it clearly indicates a direct modulation of CD34+ cell proliferation by hematopoietic cytokines, which is in agreement with other report^.^^,^^ The two cytokine combinations used in this study were selected based on preliminary experiments in which we observed that MGF + IL-6 + FP + M-CSF + G-CSF were capable of supporting myelopoiesis with little support for erythropoiesis, whereas MGF + IL-6 + IL-3 + Epo showed preferential stimulation of erythropoiesis. When IG3 was replaced by FP as part of the erythroid cytokine mixture, similar levels of erythroid progenitors were developed in culture; however, a striking increase in myeloid progenitors was observed. Similarly, when Epo was added to the myeloid cytokine mixture, no differences were found in myeloid progenitor numbers, but significant increments in the number of erythroid progenitors were It is not clear whether the observed expansion of CD34' cord blood cells is the result of true self-renewal in culture, or simply the production of more mature CD34' cells. Previous studies have shown that some CD34+ cells are capable of producing secondary (and in some cases, terciary and quaternary) primitive progenitor cells functionally similar to the parental These investigators have suggested that this might be an indication of self-renewal. However, because production of such progenitors was sustained for only 4 to 5 weeks (or four cell generations, depending on the assay system) it is possible that either ( 1) self-renewal potential is lost after few weeks in culture, or (2) self-renewal is not actually occuring under the conditions used. Indeed, in the culture system described here, CD34+ cell expansion occurred only during the first 3 weeks, after which a continuous decrease was observed. Besides the two possibilities mentioned above, it is also possible that self-renewal is a property of a cell population that, in our culture system, was rapidly diluted or not included among the three CD34+ cell subpopulations analyzed. Further studies will be necessary to address this important issue.
When each one of the three subpopulations was cultured in the presence of myeloid cytokine mixture, only myelopoiesis was observed at all time points, indicating that such a cytokine combination allowed the expansion and maturation of myeloid progenitors. Interestingly, in culturesofCD34+CD45RAL0CD7 1IoandCD34+CD45RA+CD-7 lL0 cells supplemented with erythroid cytokine mixture, production of both progenitor and mature erythroid cells was only transiently sustained, and a complete shift toward myelopoiesis was observed after the first 2 weeks of culture. Only CD34+CD45RAIoCD7 1+ cells cultured in the presence of erythroid cytokine mixture were able to produce primarily mature erythroid cells at all time points. However, CD34+ cell production in such cultures decreased below input numbers by day 29, so that the cultures could not be sustained any longer. Previous studies have shown that long-term marrow cultures (LTMC), either containing or lacking a stromal adherent layer, are unable to sustain erythropoiesis for more than 4 week^.^*"^ Even if EPO is added to the cultures, only a transient stimulation of erythropoiesis is ~bserved.~' One interpretation of the above results is that in vitro myelopoiesis is sustained longer at the expense of erythropoiesis, probably through factors produced by myeloid cells (eg, macrophages). However, the results of the present study indicate that, although the above possibility may be valid for LTMC, erythroid progenitors seem to have a reduced expansion potential as compared with myeloid progenitors, which does not allow the long-term generation of mature erythroid cells in vitro, even in the virtual absence of myeloid cells. Nevertheless, we cannot rule out the possibility that optimal conditions for long-term erythropoiesis in vitro requires cytokines and/or cells that were not present in the culture system described here.32 This issue will be addressed in future experiments.
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